Acorah Software Products - Accounts Production 18.1.170 false true false true No description of principal activity 1 December 2024 30 November 2025 30 November 2025 13011458 Dr Anurag Daudia iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 13011458 2024-11-30 13011458 2025-11-30 13011458 2024-12-01 2025-11-30 13011458 frs-core:CurrentFinancialInstruments 2025-11-30 13011458 frs-bus:PrivateLimitedCompanyLtd 2024-12-01 2025-11-30 13011458 frs-bus:FilletedAccounts 2024-12-01 2025-11-30 13011458 frs-bus:Micro-entities 2024-12-01 2025-11-30 13011458 frs-bus:AuditExempt-NoAccountantsReport 2024-12-01 2025-11-30 13011458 frs-bus:Director1 2024-12-01 2025-11-30
Registered number: 13011458
Atd Surgical Limited
Financial Statements
For The Year Ended 30 November 2025
JJW Accountants Ltd
Balance Sheet
Registered number: 13011458
2025
£
Current assets 50,371
Creditors: Amounts Falling Due Within One Year (28,010 )
NET CURRENT ASSETS 22,361
TOTAL ASSETS LESS CURRENT LIABILITIES 22,361
Accruals and deferred income (3,600 )
NET ASSETS 18,761
CAPITAL AND RESERVES 18,761

Notes

1. General Information
Atd Surgical Limited is a private company, limited by shares, incorporated in England & Wales, registered number 13011458 . The registered office is 51 Jacks Key Drive, Darwen, Lancashire, BB3 2LG.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1
1
For the year ending 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Dr Anurag Daudia
Director
31/08/2026